4//SEC Filing
Hernandez Alexandra 4
Accession 0001493152-21-007795
CIK 0000876343other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 8:00 PM ET
Size
20.7 KB
Accession
0001493152-21-007795
Insider Transaction Report
Form 4
Hernandez Alexandra
Sr Director Finance/Controller
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-03-30−6,000→ 39,200 totalExercise: $0.69Exp: 2030-03-17→ Common Shares (6,000 underlying) - Exercise/Conversion
Common Shares, no par value
2021-03-30$0.69/sh+6,000$4,151→ 6,000 total - Award
Employee Stock Option (Right to Buy)
2021-03-15+42,700→ 42,700 totalExercise: $2.43Exp: 2031-03-15→ Common Shares (42,700 underlying) - Sale
Common Shares, no par value
2021-03-30$2.23/sh−6,000$13,380→ 0 total
Footnotes (2)
- [F1]One quarter of the options vest on March 15, 2022 and the balance vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
- [F2]One quarter of the options vested on March 17, 2021 and the balance vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001841756
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 8:00 PM ET
- Size
- 20.7 KB